Teva Pharmaceutical Industries Limited
TEVA
Rank in Stocks
#481
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Share Price
$42.99
Last synced: 2026-11-09
Market Cap
$50.10B
Change (1 day)
2.98%
Change (1 year)
64.21%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Teva Pharmaceutical Industries Limited (TEVA)
Category
Healthcare
Dividend history for Teva Pharmaceutical Industries Limited (TEVA)
Teva Pharmaceutical Industries Limited (stock symbol: TEVA) made a total of 62 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $9.43
Dividend yield (TTM) : 0.00%
The sum of all dividends (adjusted for stock splits) is : $9.43
Dividend yield (TTM) : 0.00%
Dividend payments for Teva Pharmaceutical Industries Limited (TEVA) from 2002 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.24 | 0.00% |
| 2017 | $0.24 | -33.35% |
| 2016 | $0.35 | -67.93% |
| 2015 | $1.11 | -18.18% |
| 2014 | $1.35 | 6.24% |
| 2013 | $1.27 | 23.85% |
| 2012 | $1.03 | 15.51% |
| 2011 | $0.89 | 21.16% |
| 2010 | $0.73 | 22.08% |
| 2009 | $0.6 | 20.44% |
| 2008 | $0.5 | 27.09% |
| 2007 | $0.39 | 28.33% |
| 2006 | $0.31 | 14.45% |
| 2005 | $0.27 | 34.42% |
| 2004 | $0.2 | 37.66% |
| 2003 | $0.14 | 214.10% |
| 2002 | $0.046 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.24 | 0.00% |
| 2017 | $0.24 | -33.35% |
| 2016 | $0.35 | -67.93% |
| 2015 | $1.11 | -18.18% |
| 2014 | $1.35 | 6.24% |
| 2013 | $1.27 | 23.85% |
| 2012 | $1.03 | 15.51% |
| 2011 | $0.89 | 21.16% |
| 2010 | $0.73 | 22.08% |
| 2009 | $0.6 | 20.44% |
| 2008 | $0.5 | 27.09% |
| 2007 | $0.39 | 28.33% |
| 2006 | $0.31 | 14.45% |
| 2005 | $0.27 | -10.10% |
| 2004 | $0.3 | 2.91% |
| 2003 | $0.29 | 57.05% |
| 2002 | $0.18 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 13.00% |
DE
|
|
| 26.00% |
DE
|
|
| 55.00% |
JP
|
|
| 2.00% |
CH
|
|
| 39.00% |
IN
|
Questions about Teva Pharmaceutical Industries Limited's dividend per share
What is Teva Pharmaceutical Industries Limited's dividend per share?
Teva Pharmaceutical Industries Limited's dividend per share over the last twelve months is $0.24, as of Nov 2017.
What was Teva Pharmaceutical Industries Limited's dividend per share in 2017?
In 2017, Teva Pharmaceutical Industries Limited's dividend per share was $0.24, 33.35% less than in 2016 ($0.35).
How has Teva Pharmaceutical Industries Limited's dividend per share changed since 2012?
From 2012 to 2017, Teva Pharmaceutical Industries Limited's dividend per share went from $1.03 to $0.24, an average decline of 25.46% a year.